Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Blood Cells Mol Dis. 2009 Mar 4;43(1):81–87. doi: 10.1016/j.bcmd.2009.02.001

Table 1.

Statistical analysis of percentage of erythroid stage using CD71/CD235a expression profiles during expansion.

R1 R2 R3 R4 R5
CTR PV P value CTR PV P value CTR PV P value CTR PV P value CTR PV P value
Day 7 7.9±0.74 8.4±1.70 0.76 1.5±0.34 1.2±0.38 0.55 0.58±0.17 1.87±0.57 0.05* 0.5±0.11 1.5±0.36 0.02* 0.25±0.13 0.68±0.23 0.16
Day 9 5.8±0.64 9.8±2.64 0.28 1.1±0.35 2.3±1.71 0.56 2.3±0.74 30.2±6.52 0.05* 0.5±0.08 9.6±0.24 0.00** 0.5±0.09 0.28±0.11 0.40
Day 11 6.7±1.28 5.6±1.96 0.70 0.28±0.11 0.19±0.65 0.66 14.3±6.55 8.4±6.07 0.54 14.2±8.44 57.9±12.11 0.04* 0.52±0.31 0.93±0.40 0.47
Day 14 9.3±1.70 9.9±2.43 0.87 0.11±0.06 0.11±0.09 0.99 8.1±2.31 4.4±1.95 0.24 37.8±4.15 47.8±4.52 0.15 2.5±0.57 2.8±0.60 0.76

Data are presented as the mean plus standard error. CTR-controls, PV- polycythemia vera patients,

*

p< 0.05,

**

p<0.01